Charlotte Teunissen
Charlotte Teunissen
Unknown affiliation
Verified email at
Cited by
Cited by
Alzheimer's disease
P Scheltens, B De Strooper, M Kivipelto, H Holstege, G Chételat, ...
The Lancet 397 (10284), 1577-1590, 2021
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
Neurofilaments as biomarkers in neurological disorders
M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ...
Nature Reviews Neurology 14 (10), 577-589, 2018
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ...
Neurology 73 (22), 1914-1922, 2009
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
D Vogel, EJF Vereyken, JE Glim, PDAM Heijnen, M Moeton, ...
Journal of neuroinflammation 10 (1), 1-12, 2013
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ...
Nature medicine 26 (3), 387-397, 2020
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 150414, 2015
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
CE Teunissen, IMW Verberk, EH Thijssen, L Vermunt, O Hansson, ...
The Lancet Neurology 21 (1), 66-77, 2022
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need
GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ...
Alzheimer's & Dementia 15 (2), 292-312, 2019
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
Optimizing patient care and research: the Amsterdam Dementia Cohort
WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ...
Journal of Alzheimer's disease 41 (1), 313-327, 2014
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers …
H Vanderstichele, M Bibl, S Engelborghs, N Le Bastard, P Lewczuk, ...
Alzheimer's & Dementia 8 (1), 65-73, 2012
Inflammation markers in relation to cognition in a healthy aging population
CE Teunissen, MPJ Van Boxtel, H Bosma, E Bosmans, J Delanghe, ...
Journal of neuroimmunology 134 (1-2), 142-150, 2003
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
NSM Schoonenboom, FE Reesink, NA Verwey, MI Kester, CE Teunissen, ...
Neurology 78 (1), 47-54, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
The system can't perform the operation now. Try again later.
Articles 1–20